Introducing

Avicena Sentinel

Fast, Accurate, Affordable, and Scalable Pathogen Screening

The fastest and most scalable molecular diagnostics platform in the world – up to 100,000 tests per day.

Next-Generation Molecular Diagnostics

The Avicena Sentinel is the world’s fastest and most scalable molecular diagnostics platform.

Available in two versions, the Sentinel ULTRA and Sentinel Mini cater to diverse testing needs, making it economically viable for both low and high-volume scenarios.

With accuracy comparable to PCR, the Avicena Sentinel outperforms in speed and affordability, while preserving the capability to screen for multiple pathogens simultaneously.

Effortless Saliva Sample Collection

Quick Saliva Sample Collection

Simply swab your mouth with our microswab to gather the optimal saliva volume. 

 

Secure in Barcoded Sample Tube

Secure the swab in the provided barcode-labeled sample tube that contains a stabilising buffer solution.

 

The Future of Biosecurity

Sentinel is flexible and can rapidly adapt to test for current and emerging pathogen threats

Emerging Threats

Lumpy Skin Disease
Japanese Encephalitis Virus
Monkeypox
Zika Virus
Dengue
Malaria
Bioengineered Pathogens

 

Blood Banks

HIV
Hepatitis B
Hepatitis C

Antibiotic Resistant Pathogens

Drug-Resistant Tuberculosis
MRSA
VRE
Pseudomonas
Acinetobacter

Influenza

Human & Zoonotic influenza
Emerging Pandemic Flu Threats

The Sentinel Platform

Sentinel Mini

Up to 384 hourly throughput
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting

 

Sentinel ULTRA V3

Up to 100,000 daily throughput
Up to 10x faster than PCR
Continuous Flow Processing
Fully Automated
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting

 

TGA Authorised

Sentinel has achieved a Class 1 IVD listing on the Australian Register of Therapeutic Goods (ARTG) under the TGA.

CE-Marked Chemistry

CE-Mark for COVID test chemistry developed by Hayat Genetics, acquired by Avicena Systems.

 

Patent-Pending

Avicena holds several patent pending innovations that enable our groundbreaking performance.

Intended Use

The Avicena Sentinel instrument is intended for trained laboratory professionals to run isothermal amplification assays. Diagnostic use of the Sentinel requires IVD reagents and laboratory workflows which have been authorised by relevant regulatory agencies in each jurisdiction and by Avicena Systems as compatible with the instrument.